CX3CR1 biomarker Study

  • Title: CX3CR1 biomarker Study
  • Participating center and contact:
    • UniversitätsSpital Zürich
    • Prof. Dr. med. Michael Scharl
    • michael.scharl@usz.ch
  • Details: 
    • The aim of this clinical biomarker study is to investigate whether the presence of a genetic variation within the CX3CR1 gene locus can be used as predictive biomarker for the disease course of CD patients.
    • By analyzing and correlating ASCA serum levels, CX3CR1 polymorphism and disease characteristics using biosamples from 450 SIBDCS patients, it will be tested whether presence of the CX3CR1 gene variation is associated with a complicated disease behavior.
Subscribe to our Newsletter

Sign up with your e-mail to receive IBDnet news and updates. We respect your privacy.